Evidence map›Paper›PMID 28278234›Full record

ArticlePloS one2017

Heterogeneity of mast cells and expression of Annexin A1 protein in a second degree burn model with silver sulfadiazine treatment.

Helena Ribeiro Souza, Lucas Ribeiro de Azevedo, Lucas Possebon, Sara de Souza Costa, Melina Mizusaki Iyomasa-Pilon, Sonia Maria Oliani, Ana Paula Girol

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. AcCells · 2025
    Article
  3. Innate Immune System Response to Burn Damage-Focus on Cytokine Alteration.International journal of molecular sciences · 2022
    Review
  4. Effect ofF1000Research · 2022
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Helena Ribeiro SouzaIntegrated College Padre Albino Foundation (FIPA), Catanduva, São Paulo, Brazil.
Lucas Ribeiro de AzevedoDepartment of Biology, Laboratory of Immunomorphology, São Paulo State University, (UNESP), São José do Rio Preto, São Paulo, Brazil.
Lucas PossebonDepartment of Biology, Laboratory of Immunomorphology, São Paulo State University, (UNESP), São José do Rio Preto, São Paulo, Brazil.
Sara de Souza CostaDepartment of Biology, Laboratory of Immunomorphology, São Paulo State University, (UNESP), São José do Rio Preto, São Paulo, Brazil.
Melina Mizusaki Iyomasa-PilonIntegrated College Padre Albino Foundation (FIPA), Catanduva, São Paulo, Brazil.
Sonia Maria OlianiDepartment of Biology, Laboratory of Immunomorphology, São Paulo State University, (UNESP), São José do Rio Preto, São Paulo, Brazil.
Ana Paula GirolIntegrated College Padre Albino Foundation (FIPA), Catanduva, São Paulo, Brazil.
Universidade Estadual Paulista (Unesp) · BRFundação Padre Albino · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mast cells (MCs) participate in all stages of skin healing and one of their mediators is the Annexin A1 protein (AnxA1), linked to inflammation, proliferation, migration and apoptosis processes, but not studied in thermal burns yet. Therefore, our objectives were to evaluate the behavior of MCs and AnxA1 in a second degree burn model, treated or not with silver sulfadiazine 1% (SDP 1%) and associated to macrophages quantification and cytokines dosages. MCs counts showed few cells in the early stages of repair but increased MCs in the final phases in the untreated group. The normal skin presented numerous tryptase-positive MCs that were reduced after burning in all analyzed periods. Differently, few chymase-positive MCs were observed in the early stages of healing, however, increased chymase-positive MCs were found at the final phase in the untreated group. MCs also showed high immunoreactivity for AnxA1 on day 3 in both groups. In the tissue there was a strong protein expression in the early stages of healing, but in the final phases only in the SDP treated animals. TNF-α, IL-1β, IL-6, IL-10 and MCP-1 levels and macrophages quantification were increased in inflammation and reepithelialization phases. Reduced IL-1β, IL-6 and IL-10 levels and numerous macrophages occurred in the treated animals during tissue repair. Our results indicate modulation in the profile of MCs and AnxA1expression during healing by the treatment with SDP 1%, pointing them as targets for therapeutic interventions on skin burns.

Indexed as

AnimalsAnnexin A1BurnsCell CountCell ProliferationCytokinesCytoplasmDermisDisease Models, AnimalEpidermisGene Expression RegulationHistamineMacrophagesMast CellsRatsRats, WistarAnnexin A1CytokinesHistamineSilver Sulfadiazine

Identifiers

PMID28278234
PMCPMC5344483
OpenAlexW2593718467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.